Granite Point Capital Management, L.P. Neuronetics, Inc. Transaction History

Granite Point Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$6.22 - $15.54 $1.64 Million - $4.1 Million	-263,596 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$10.15 - $17.25 $4.6 Million - $7.81 Million	-452,730 Reduced 63.2%	263,596 $4.22 Million
Q1 2021 May 12, 2021	SELL	$10.6 - $21.27 $5.62 Million - $11.3 Million	-530,456 Reduced 42.55%	716,326 $8.86 Million
Q4 2020 Feb 05, 2021	SELL	$4.95 - $11.45 $263,429 - $609,346	-53,218 Reduced 4.09%	1,246,782 $13.9 Million
Q3 2020 Nov 06, 2020	BUY	$1.82 - $5.87 $2.37 Million - $7.63 Million	1,300,000 New	1,300,000 $6.32 Million

18.5M

200

3.6K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $51.9M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.